INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Mar 07, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 22,931 | $335.06 | 17,374,158 |
Aug 13, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,000 | $52.03 | 46,299 |
Aug 13, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,000 | -- | 14,079 |
May 24, 2022 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 23,077 | -- | 322,489 |
Feb 09, 2024 |
EVP & General Mgr, Industrial
Trans History: 359
|
EVP & General Mgr, Industrial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,125 | $381.40 | 47,153 |
Feb 09, 2024 |
EVP & General Mgr, Industrial
Trans History: 359
|
EVP & General Mgr, Industrial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,125 | -- | -- |
Aug 23, 2023 |
EVP & General Mgr, Industrial
Trans History: 359
|
EVP & General Mgr, Industrial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,125 | $381.40 | 44,633 |
Aug 23, 2023 |
EVP & General Mgr, Industrial
Trans History: 359
|
EVP & General Mgr, Industrial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,125 | -- | 23,125 |
Jan 31, 2012 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,128 | $21.92 | 32,500 |
Jan 31, 2012 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,128 | -- | 12,500 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.